Literature DB >> 25466851

Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.

Zhi-Rui Zhou1, Shi-Xin Liu2, Tian-Song Zhang3, Ling-Xiao Chen4, Jun Xia5, Zhi-De Hu6, Bo Li7.   

Abstract

BACKGROUND: Long-course chemoradiotherapy (LCRT) with delayed surgery or short-course radiotherapy (SCRT) with immediate surgery is probably the most frequent regimen in the treatment of rectal cancer. Debate is still going on whether SCRT or LCRT is more effective. So we performed this meta-analysis to evaluate the safety and efficacy of SCRT with immediate surgery versus LCRT with delayed surgery for the management of rectal cancer.
METHODS: Literature were searched from PubMed, Embase, Web of science, Cochrane Library up to May, 2014. Quality of the randomized controlled trials (RCTs) was evaluated according to the Cochrane's risk of bias tool of RCT. RevMan 5.3 was used for statistical analysis. Pooled risk ratio (RR) and 95% confidence interval (CI) were calculated. Subgroup analysis and sensitivity analysis were employed to explore heterogeneity.
RESULTS: 16 trials were included in the qualitative systematic review. 12 trials were included in meta-analyses. 4 of them were RCTs; other 8 were non-RCTs. Meta-analysis demonstrated that there were no significant differences in overall survival (OS), disease free survival (DFS), local recurrence rate (LRR), distant metastasis rate (DMR), sphincter preservation rate, R0 resection rate and late toxicity. Compared with SCRT, LCRT obviously increased pCR rate [RR=0.15, 95%CI (0.08, 0.28), P=0.003], while LCRT obviously increased the grade 3-4 acute toxicity [RR=0.13, 95%CI (0.06, 0.28), P<0.00001].
CONCLUSIONS: SCRT with immediate surgery is as effective as LCRT with delayed surgery for treatment of rectal cancer in terms of OS, DFS, LRR, DMR, Sphincter preservation rate, R0 resection rate and late toxicity. Though LCRT increased pCR rate, LCRT also increased acute toxicity compared with SCRT. SCRT is a better choice in centers with a long waiting list or lack of medical resources.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; Meta-analysis; Preoperative radiotherapy; Rectal cancer

Mesh:

Year:  2014        PMID: 25466851     DOI: 10.1016/j.suronc.2014.10.003

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  21 in total

1.  Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials.

Authors:  Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Mara Ghilardi; Veronica Lonati; Sandro Barni
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 2.  Update on advances and controversy in rectal cancer treatment.

Authors:  S Biondo; D Fraccalvieri; T Golda; R Frago; L Trenti; E Kreisler
Journal:  Tech Coloproctol       Date:  2016-01-12       Impact factor: 3.781

Review 3.  Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.

Authors:  Rupert Langer; Karen Becker
Journal:  Virchows Arch       Date:  2017-09-16       Impact factor: 4.064

4.  Eastern Canadian Colorectal Cancer Consensus Conference 2017.

Authors:  S F McGee; W AlGhareeb; C H Ahmad; D Armstrong; S Babak; S Berry; J Biagi; C Booth; D Bossé; P Champion; B Colwell; N Finn; R Goel; S Gray; J Green; M Harb; A Hyde; A Jeyakumar; D Jonker; S Kanagaratnam; P Kavan; A MacMillan; A Muinuddin; N Patil; G Porter; E Powell; R Ramjeesingh; M Raza; S Rorke; M Seal; F Servidio-Italiano; J Siddiqui; J Simms; L Smithson; S Snow; E St-Hilaire; T Stuckless; A Tate; M Tehfe; M Thirlwell; E Tsvetkova; M Valdes; M Vickers; K Virik; S Welch; C Marginean; T Asmis
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

5.  Gender-related prognostic significance of clinical and biological tumor features in rectal cancer patients receiving short-course preoperative radiotherapy.

Authors:  Anna Gasinska; Zbigniew Darasz; Agnieszka Adamczyk; Beata Biesaga; Joanna Niemiec; Marian Reinfuss
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-01

Review 6.  Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.

Authors:  Sami A Chadi; Marianna Berho; Steven D Wexner
Journal:  Langenbecks Arch Surg       Date:  2015-08-07       Impact factor: 3.445

7.  Tumor stage in patients operated for rectal cancer: a comparison of the pre-operative MR and the resection specimen, with specific attention to the effect of neo-adjuvant radiotherapy.

Authors:  Elmer E van Eeghen; Sandra D Bakker; Gerwin Fransen; Marcel J Flens; Ruud J L F Loffeld
Journal:  J Gastrointest Oncol       Date:  2017-08

8.  MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.

Authors:  Antonella Petrillo; Roberta Fusco; Vincenza Granata; Sergio Venanzio Setola; Mario Sansone; Daniela Rega; Paolo Delrio; Francesco Bianco; Giovanni Maria Romano; Fabiana Tatangelo; Antonio Avallone; Biagio Pecori
Journal:  Med Oncol       Date:  2017-11-18       Impact factor: 3.064

9.  Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study.

Authors:  Elmer E van Eeghen; Frank den Boer; Sandra D Bakker; Ruud J L F Loffeld
Journal:  J Gastrointest Oncol       Date:  2016-06

Review 10.  Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

Authors:  Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-07-02       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.